Quidel | QDEL - Selling And Administration Expenses


Quidel reported $194.4M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Agilent USD 476M 48M Dec/2025
Avanos Medical USD 78.8M 1.2M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Bruker USD 247.2M 4.7M Dec/2025
Cerus USD 19.33M 1.55M Dec/2024
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Danaher USD 2.03B 35M Dec/2025
Haemonetics USD 109.15M 7.54M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
Illumina USD 283M 27M Dec/2025
IQVIA Holdings USD 468M 46M Dec/2025
Merit Medical Systems USD 114.83M 7.45M Dec/2025
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Myriad Genetics USD 122.3M 6.7M Dec/2025
Neogen USD 107.5M 1.56M Sep/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Quidel USD 194.4M 7.5M Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
STAAR Surgical USD 38.94M 20.44M Dec/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Waters USD 240.01M 25.78M Dec/2025